EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,542,960 | -39.2% | 161,253 | -25.1% | 0.00% | 0.0% |
| Q2 2023 | $4,184,071 | -13.0% | 215,230 | +26.9% | 0.00% | 0.0% |
| Q1 2023 | $4,810,020 | +16.0% | 169,546 | +19.5% | 0.00% | 0.0% |
| Q4 2022 | $4,147,561 | +43.1% | 141,894 | +29.4% | 0.00% | 0.0% |
| Q3 2022 | $2,898,000 | -60.6% | 109,677 | -33.8% | 0.00% | -50.0% |
| Q2 2022 | $7,357,000 | -16.6% | 165,582 | -7.1% | 0.00% | 0.0% |
| Q1 2022 | $8,825,000 | +60.7% | 178,306 | +65.3% | 0.00% | +100.0% |
| Q4 2021 | $5,493,000 | -8.0% | 107,868 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $5,972,000 | -29.4% | 107,076 | -45.9% | 0.00% | -50.0% |
| Q2 2021 | $8,464,000 | +47.8% | 197,762 | +44.1% | 0.00% | +100.0% |
| Q1 2021 | $5,728,000 | -17.0% | 137,222 | -7.4% | 0.00% | -50.0% |
| Q4 2020 | $6,900,000 | -2.7% | 148,169 | -11.2% | 0.00% | 0.0% |
| Q3 2020 | $7,088,000 | +21.7% | 166,866 | +37.5% | 0.00% | 0.0% |
| Q2 2020 | $5,822,000 | -61.3% | 121,343 | -62.9% | 0.00% | -60.0% |
| Q1 2020 | $15,055,000 | +81.3% | 327,293 | +136.9% | 0.01% | +150.0% |
| Q4 2019 | $8,302,000 | +116.0% | 138,173 | +103.4% | 0.00% | +100.0% |
| Q3 2019 | $3,844,000 | -35.1% | 67,940 | -36.1% | 0.00% | -50.0% |
| Q2 2019 | $5,922,000 | -10.4% | 106,352 | -18.7% | 0.00% | 0.0% |
| Q1 2019 | $6,607,000 | +0.9% | 130,860 | -19.4% | 0.00% | 0.0% |
| Q4 2018 | $6,546,000 | -43.8% | 162,457 | -3.3% | 0.00% | -33.3% |
| Q3 2018 | $11,643,000 | +28.1% | 167,934 | +39.8% | 0.00% | +50.0% |
| Q2 2018 | $9,088,000 | +68.4% | 120,115 | +17.2% | 0.00% | +100.0% |
| Q1 2018 | $5,398,000 | -9.2% | 102,444 | -7.9% | 0.00% | 0.0% |
| Q4 2017 | $5,943,000 | +11.6% | 111,257 | +24.6% | 0.00% | 0.0% |
| Q3 2017 | $5,326,000 | -38.4% | 89,306 | -18.5% | 0.00% | -50.0% |
| Q2 2017 | $8,644,000 | -32.4% | 109,581 | -28.9% | 0.00% | -33.3% |
| Q1 2017 | $12,784,000 | +270.3% | 154,137 | +254.3% | 0.00% | +200.0% |
| Q4 2016 | $3,452,000 | +56.8% | 43,501 | +38.3% | 0.00% | 0.0% |
| Q3 2016 | $2,201,000 | +102.3% | 31,446 | +12.1% | 0.00% | – |
| Q2 2016 | $1,088,000 | -76.2% | 28,050 | -75.1% | 0.00% | -100.0% |
| Q1 2016 | $4,569,000 | -25.9% | 112,812 | +62.3% | 0.00% | 0.0% |
| Q4 2015 | $6,165,000 | +1118.4% | 69,522 | +918.8% | 0.00% | – |
| Q3 2015 | $506,000 | -65.4% | 6,824 | -62.3% | 0.00% | – |
| Q2 2015 | $1,463,000 | +255.1% | 18,098 | +83.9% | 0.00% | – |
| Q1 2015 | $412,000 | – | 9,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |